Advertisement

Human Cell

, Volume 32, Issue 2, pp 150–159 | Cite as

Sevoflurane prevents hypoxia/reoxygenation-induced cardiomyocyte apoptosis by inhibiting PI3KC3-mediated autophagy

  • Yanfeng Lu
  • Min BuEmail author
  • Huifang Yun
Research Article
  • 73 Downloads

Abstract

Cardiomyocyte apoptosis plays an important role in ischemia/reperfusion (I/R)-induced myocardial injury. Autophagy is suggested to be widely implicated in regulating cell survival and death. The cardioprotection of sevoflurane postconditioning has been long recognized, but the underlying mechanisms are not well understood. This study aims to investigate whether the cardioprotective effects of sevoflurane are associated with autophagy regulation. An in vitro hypoxia/reoxygenation (H/R) model was established in human induced pluripotent stem cell-derived cardiomyocytes. The results showed that autophagy was activated in cardiomyocytes upon to H/R conditions, followed by increased LC3B puncta. Sevoflurane treatment or autophagy inhibition markedly attenuated H/R-induced cardiomyocyte apoptosis. However, the effect of sevoflurane was reversed by autophagy induction. Moreover, sevoflurane significantly blocked H/R-induced autophagosome formation and autophagic flux. Mechanistically, we found that sevoflurane regulated H/R-induced autophagy through mTOR-independent mechanism. Sevoflurane inhibited the increase in PI3KC3 phosphorylation and Beclin-1/PI3KC3 complex formation under H/R conditions. Taken together, these results demonstrate that sevofluran ameliorates H/R-induced cardiomyocyte apoptosis by autophagy inhibition via reducing Beclin-1/PI3KC3 formation and PI3KC3 activity. This novel mechanism may help to better understand the functional role of sevoflurane for the treatment of cardiac I/R injury.

Keywords

Hypoxia/reoxygenation Cardiomyocyte apoptosis Autophagy Sevoflurane PI3KC3 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Brown IAM, Diederich L, Good ME, DeLalio LJ, Murphy SA, Cortese-Krott MM, et al. Vascular smooth muscle remodeling in conductive and resistance arteries hypertension. Arterioscler Thromb Vasc Biol. 2018;38(9):1969–85.  https://doi.org/10.1161/ATVBAHA.118.311229.CrossRefGoogle Scholar
  2. 2.
    Doi T, Kataoka Y, Noguchi T, Shibata T, Nakashima T, Kawakami S, et al. Coronary artery ectasia predicts future cardiac events in patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol. 2017;37(12):2350–5.  https://doi.org/10.1161/ATVBAHA.117.309683.CrossRefGoogle Scholar
  3. 3.
    Wang Z, Stuckey DJ, Murdoch CE, Camelliti P, Lip GYH, Griffin M. Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor. Cell Death Dis. 2018;9(6):613.  https://doi.org/10.1038/s41419-018-0573-2.CrossRefGoogle Scholar
  4. 4.
    Zhang Y, Liu YY, Li Q, Pan CS, Fan JY, Wang CS, et al. Panax Notoginseng Saponins restrains ischemiareperfusion-induced rat mesenteric microcirculatory disturbance. World J Tradit Chin Med. 2015;3:1–8. https://doi.org/10.15806/j.issn.2311-8571.2014.0011.Google Scholar
  5. 5.
    Ma LL, Ma X, Kong FJ, Guo JJ, Shi HT, Zhu JB, et al. Mammalian target of rapamycin inhibition attenuates myocardial ischaemia-reperfusion injury in hypertrophic heart. J Cell Mol Med. 2018;22(3):1708–19.  https://doi.org/10.1111/jcmm.13451.CrossRefGoogle Scholar
  6. 6.
    Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012;298:229–317.  https://doi.org/10.1016/B978-0-12-394309-5.00006-7.CrossRefGoogle Scholar
  7. 7.
    Xue Q, Pei H, Liu Q, Zhao M, Sun J, Gao E, et al. MICU1 protects against myocardial ischemia/reperfusion injury and its control by the importer receptor Tom70. Cell Death Dis. 2017;8(7):e2923.  https://doi.org/10.1038/cddis.2017.280.CrossRefGoogle Scholar
  8. 8.
    Palojoki E, Saraste A, Eriksson A, Pulkki K, Kallajoki M, Voipio-Pulkki LM, et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol. 2001;280(6):H2726-31.  https://doi.org/10.1152/ajpheart.2001.280.6.H2726.CrossRefGoogle Scholar
  9. 9.
    Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med. 2012;366(1):54–63.  https://doi.org/10.1056/NEJMra1112570.CrossRefGoogle Scholar
  10. 10.
    Liu H, Jing X, Dong A, Bai B, Wang H. Overexpression of TIMP3 protects against cardiac ischemia/reperfusion injury by inhibiting myocardial apoptosis through ROS/Mapks pathway. Cell Physiol Biochem. 2017;44(3):1011–23.  https://doi.org/10.1159/000485401.CrossRefGoogle Scholar
  11. 11.
    Guo Y, Tukaye DN, Wu WJ, Zhu X, Book M, Tan W, et al. The COX-2/PGI2 receptor axis plays an obligatory role in mediating the cardioprotection conferred by the late phase of ischemic preconditioning. PLoS One. 2012;7(7):e41178.  https://doi.org/10.1371/journal.pone.0041178.CrossRefGoogle Scholar
  12. 12.
    Chen Z, Luo H, Zhuang M, Cai L, Su C, Lei Y, et al. Effects of ischemic preconditioning on ischemia/reperfusion-induced arrhythmias by upregulatation of connexin 43 expression. J Cardiothorac Surg. 2011;6:80.  https://doi.org/10.1186/1749-8090-6-80.CrossRefGoogle Scholar
  13. 13.
    Lemoine S, Tritapepe L, Hanouz JL, Puddu PE. The mechanisms of cardio-protective effects of desflurane and sevoflurane at the time of reperfusion: anaesthetic post-conditioning potentially translatable to humans? Br J anaesthesia. 2016;116(4):456–75.  https://doi.org/10.1093/bja/aev451.CrossRefGoogle Scholar
  14. 14.
    Kloner RA, Rezkalla SH. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovascular Res. 2006;70(2):297–307.  https://doi.org/10.1016/j.cardiores.2006.01.012.CrossRefGoogle Scholar
  15. 15.
    Holaday DA, Smith FR. Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology. 1981;54(2):100–6.CrossRefGoogle Scholar
  16. 16.
    Guerrero Orriach JL, Galan Ortega M, Ramirez Aliaga M, Iglesias P, Rubio Navarro M, Cruz Manas J. Prolonged sevoflurane administration in the off-pump coronary artery bypass graft surgery: beneficial effects. J Crit Care. 2013;28(5):879 e13-8.  https://doi.org/10.1016/j.jcrc.2013.06.004.CrossRefGoogle Scholar
  17. 17.
    Qiao SG, Sun Y, Sun B, Wang A, Qiu J, Hong L, et al. Sevoflurane postconditioning protects against myocardial ischemia/reperfusion injury by restoring autophagic flux via an NO-dependent mechanism. Acta Pharmacol Sin. 2018.  https://doi.org/10.1038/s41401-018-0066-y.Google Scholar
  18. 18.
    Zhang J, Wang C, Yu S, Luo Z, Chen Y, Liu Q, et al. Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling. Sci Rep. 2014;4:7317.  https://doi.org/10.1038/srep07317.CrossRefGoogle Scholar
  19. 19.
    Yao Y, Li L, Li L, Gao C, Shi C. Sevoflurane postconditioning protects chronically-infarcted rat hearts against ischemia-reperfusion injury by activation of pro-survival kinases and inhibition of mitochondrial permeability transition pore opening upon reperfusion. Biol Pharm Bull. 2009;32(11):1854–61.CrossRefGoogle Scholar
  20. 20.
    Yorimitsu T, Klionsky DJ. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005;12(Suppl 2):1542–52.  https://doi.org/10.1038/sj.cdd.4401765.CrossRefGoogle Scholar
  21. 21.
    Apel A, Zentgraf H, Buchler MW, Herr I. Autophagy-A double-edged sword in oncology. Int J Cancer. 2009;125(5):991–5.  https://doi.org/10.1002/ijc.24500.CrossRefGoogle Scholar
  22. 22.
    An Y, Liu WJ, Xue P, Ma Y, Zhang LQ, Zhu B, et al. Autophagy promotes MSC-mediated vascularization in cutaneous wound healing via regulation of VEGF secretion. Cell Death Dis. 2018;9(2):58.  https://doi.org/10.1038/s41419-017-0082-8.CrossRefGoogle Scholar
  23. 23.
    Li H, Zhang X, Tan J, Sun L, Xu LH, Jiang YG, et al. Propofol postconditioning protects H9c2 cells from hypoxia/reoxygenation injury by inducing autophagy via the SAPK/JNK pathway. Mol Med Rep. 2018;17(3):4573–80.  https://doi.org/10.3892/mmr.2018.8424.Google Scholar
  24. 24.
    Wu Y, Wang J, Yu X, Li D, Han X, Fan L. Sevoflurane ameliorates doxorubicin-induced myocardial injury by affecting the phosphorylation states of proteins in PI3K/Akt/mTOR signaling pathway. Cardiol J. 2017;24(4):409–18.  https://doi.org/10.5603/CJ.a2017.0018.CrossRefGoogle Scholar
  25. 25.
    Itakura E, Kishi C, Inoue K, Mizushima N. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell. 2008;19(12):5360–72.  https://doi.org/10.1091/mbc.E08-01-0080.CrossRefGoogle Scholar
  26. 26.
    Funderburk SF, Wang QJ, Yue Z. The Beclin 1-VPS34 complex–at the crossroads of autophagy and beyond. Trends Cell Biol. 2010;20(6):355–62.  https://doi.org/10.1016/j.tcb.2010.03.002.CrossRefGoogle Scholar
  27. 27.
    Li SJ, Sun SJ, Gao J, Sun FB. Wogonin induces Beclin-1/PI3K and reactive oxygen species-mediated autophagy in human pancreatic cancer cells. Oncol Lett. 2016;12(6):5059–67.  https://doi.org/10.3892/ol.2016.5367.CrossRefGoogle Scholar
  28. 28.
    Acimovic I, Vilotic A, Pesl M, Lacampagne A, Dvorak P, Rotrekl V, et al. Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. BioMed Res Int. 2014;2014:512831.  https://doi.org/10.1155/2014/512831.CrossRefGoogle Scholar
  29. 29.
    Navarrete EG, Liang P, Lan F, Sanchez-Freire V, Simmons C, Gong T, et al. Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays. Circulation. 2013;128(11 Suppl 1):3–13.  https://doi.org/10.1161/CIRCULATIONAHA.112.000570.CrossRefGoogle Scholar
  30. 30.
    Zhao L, Zhang B. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci Rep. 2017;7:44735.  https://doi.org/10.1038/srep44735.CrossRefGoogle Scholar
  31. 31.
    Maillet A, Tan K, Chai X, Sadananda SN, Mehta A, Ooi J, et al. Modeling doxorubicin-induced cardiotoxicity in human pluripotent stem cell derived-cardiomyocytes. Sci Rep. 2016;6:25333.  https://doi.org/10.1038/srep25333.CrossRefGoogle Scholar
  32. 32.
    Brodarac A, Saric T, Oberwallner B, Mahmoodzadeh S, Neef K, Albrecht J, et al. Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation. Stem Cell Res Therapy. 2015;6:83.  https://doi.org/10.1186/s13287-015-0057-6.CrossRefGoogle Scholar
  33. 33.
    Hou Z, Zhou Y, Yang H, Liu Y, Mao X, Qin X, et al. Alpha7 nicotinic acetylcholine receptor activation protects against myocardial reperfusion injury through modulation of autophagy. Biochem Biophys Res Commun. 2018;500(2):357–64.  https://doi.org/10.1016/j.bbrc.2018.04.077.CrossRefGoogle Scholar
  34. 34.
    Qiu R, Li W, Liu Y. MicroRNA-204 protects H9C2 cells against hypoxia/reoxygenation-induced injury through regulating SIRT1-mediated autophagy. Biomed Pharmacother. 2018;100:15–9.  https://doi.org/10.1016/j.biopha.2018.01.165.CrossRefGoogle Scholar
  35. 35.
    Tang BD, Xia X, Lv XF, Yu BX, Yuan JN, Mai XY, et al. Inhibition of Orai1-mediated Ca(2+) entry enhances chemosensitivity of HepG2 hepatocarcinoma cells to 5-fluorouracil. J Cell Mol Med. 2017;21(5):904–15.  https://doi.org/10.1111/jcmm.13029.CrossRefGoogle Scholar
  36. 36.
    Sharif T, Martell E, Dai C, Ghassemi-Rad MS, Lee K, Singh SK, et al. Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells. Cell Death Dis. 2018;9(10):990.  https://doi.org/10.1038/s41419-018-0997-8.CrossRefGoogle Scholar
  37. 37.
    Xie H, Liu Q, Qiao S, Jiang X, Wang C. Delayed cardioprotection by sevoflurane preconditioning: a novel mechanism via inhibiting Beclin 1-mediated autophagic cell death in cardiac myocytes exposed to hypoxia/reoxygenation injury. Int J Clin Exp Pathol. 2015;8(1):217–26.Google Scholar
  38. 38.
    Liu Y, Hu M, Luo D, Yue M, Wang S, Chen X, et al. Class III PI3K positively regulates platelet activation and thrombosis via PI(3)P-directed function of NADPH oxidase. Arterioscler Thromb Vasc Biol. 2017;37(11):2075–86.  https://doi.org/10.1161/ATVBAHA.117.309751.CrossRefGoogle Scholar
  39. 39.
    Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem. 2007;282(8):5641–52.  https://doi.org/10.1074/jbc.M609532200.CrossRefGoogle Scholar
  40. 40.
    Shintani T, Yamazaki F, Katoh T, Umekawa M, Matahira Y, Hori S, et al. Glucosamine induces autophagy via an mTOR-independent pathway. Biochem Biophys Res Commun. 2010;391(4):1775–9.  https://doi.org/10.1016/j.bbrc.2009.12.154.CrossRefGoogle Scholar
  41. 41.
    Sasaki T, Takasuga S, Sasaki J, Kofuji S, Eguchi S, Yamazaki M, et al. Mammalian phosphoinositide kinases and phosphatases. Progress Lipid Res. 2009;48(6):307–43.  https://doi.org/10.1016/j.plipres.2009.06.001.CrossRefGoogle Scholar
  42. 42.
    Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol. 2010;11(5):329–41.  https://doi.org/10.1038/nrm2882.CrossRefGoogle Scholar
  43. 43.
    Obara K, Noda T, Niimi K, Ohsumi Y. Transport of phosphatidylinositol 3-phosphate into the vacuole via autophagic membranes in Saccharomyces cerevisiae. Genes Cells. 2008;13(6):537–47.  https://doi.org/10.1111/j.1365-2443.2008.01188.x.CrossRefGoogle Scholar

Copyright information

© Japan Human Cell Society and Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of AnesthesiologyChangzhou No.2 People’s Hospital, The Affiliated Hospital of Nanjing Medical UniversityChangzhouChina

Personalised recommendations